Stay updated on ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Sign up to get notified when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.

Latest updates to the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page
- CheckyesterdayChange DetectedThe page footer version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/update release rather than a change to the clinical trial information presented.SummaryDifference0.0%

- Check8 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2. This appears to be a system-level update with no visible changes to study content or layout.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check44 days agoChange DetectedFooter revision label updated to v3.4.3, replacing the previous v3.4.2 label.SummaryDifference0.0%

- Check72 days agoChange DetectedA new Revision: v3.4.2 banner was added, and the older Revision: v3.4.1 banner as well as the government funding notice banner were removed.SummaryDifference0.4%

- Check79 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status, with links to cc.nih.gov and opm.gov, and updated the revision to v3.4.1. The previous revision notice v3.4.0 was removed.SummaryDifference0.4%

Stay in the know with updates to ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Enter your email address, and we'll notify you when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.